2m 2m 2m 2m 2m 2m 2m
Konink Phil Sp ADR (PHG)
NYSE
$30.40+$0.20 (+0.66%)
Price as of Nov 12, 2026 9:14 AM EST- $29.5BMarket Cap
- 10.66%1-Year Change
- Medical DevicesIndustry
Konink Phil Sp ADR (PHG)
$30.40+$0.20 (+0.66%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 20.9B +11.71% | 18.8B -6.60% | 20.1B +12.63% | 17.8B +3.91% | |
Cost of Revenue | 11.5B +7.69% | 10.7B -9.99% | 11.8B +11.42% | 10.6B +6.46% | |
Gross Profit | 9.5B +17.02% | 8.1B -1.73% | 8.2B +14.41% | 7.2B +0.36% | |
Sales and Marketing Expense | 5.1B +9.26% | 4.7B -6.63% | 5.0B +8.47% | 4.6B +8.24% | |
Research and Development Expense | -2.0B +9.85% | -1.8B -12.96% | -2.1B -0.68% | -2.1B +16.45% | |
Depreciation and Amortization Expense | 281.9M -30.89% | 407.9M +27.28% | 320.5M -11.71% | 363.0M -72.56% | |
Total Operating Expenses | 737.7M +21.81% | 605.6M -9.86% | 671.9M +0.13% | 671.0M +12.02% | |
Operating Profit | 1.7B +203.87% | 550.5M +533.15% | -127.1M -91.69% | -1.5B -376.49% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -338.3M +12.88% | -299.7M -2.10% | -306.1M +30.26% | -235.0M +47.80% | |
Interest Income and Expense and Net | -338.3M +12.88% | -299.7M -2.10% | -306.1M +30.26% | -235.0M +47.80% | |
Total Nonoperating Income and Expense | 102.2M -83.35% | 613.9M +396.03% | 123.8M -2.54% | 127.0M -31.72% | |
Income before Taxes | 1.1B +245.07% | -726.3M +41.96% | -511.7M -68.12% | -1.6B -148.30% | |
Income Taxes | 331.3M -66.94% | 1.0B +1,342.17% | -80.7M -28.61% | -113.0M +9.71% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 1.1B +245.07% | -726.3M +41.96% | -511.7M -68.12% | -1.6B -148.30% | |
Net Income from Continuing Operations Applicable to Common | 1.1B +245.07% | -726.3M +41.96% | -511.7M -68.12% | -1.6B -148.30% | |
Basic EPS and Net Income | 0.94 +225.33% | -0.75 +47.06% | -0.51 -71.98% | -1.82 -149.59% | |
Diluted EPS and Net Income | 0.93 +224.00% | -0.75 +47.06% | -0.51 -71.98% | -1.82 -149.86% | |
Basic Weighted Average Shares | 948.2M +1.59% | 933.4M +1.74% | 917.4M +4.06% | 881.6M -2.51% | |
Diluted Weighted Average Shares | 948.2M +1.59% | 933.4M +1.74% | 917.4M +4.06% | 881.6M -2.51% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.3B +31.36% | 2.5B +20.96% | 2.1B +76.23% | 1.2B -49.11% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 3.3B +31.36% | 2.5B +20.96% | 2.1B +76.23% | 1.2B -49.11% | |
Total Current Assets | 11.7B +11.87% | 10.4B -5.06% | 11.0B +7.07% | 10.3B -0.85% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 2.2B -9.58% | 2.5B -10.64% | 2.7B +4.02% | 2.6B -2.26% | |
Total Long-Term Assets | 20.0B +1.31% | 19.7B -8.31% | 21.5B +5.30% | 20.4B -0.89% | |
Total Assets | 31.7B +4.97% | 30.2B -7.21% | 32.5B +5.89% | 30.7B -0.88% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 61.1M -36.20% | 95.7M N/A | N/A N/A | 500.0M 0.00% | |
Total Current Liabilities | 8.8B +4.06% | 8.5B -7.44% | 9.2B +15.43% | 7.9B +6.50% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 9.9B +8.50% | 9.1B -8.66% | 10.0B +5.69% | 9.5B +4.80% | |
Total Liabilities | 18.7B +6.36% | 17.6B +76,026.09% | -23.2M +10.51% | -21.0M -95.98% | |
Retained Earnings | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Stockholders Equity | 12.9B +3.01% | 12.5B -5.98% | 13.3B +0.34% | 13.3B -8.23% | |
Total Shares Outstanding | 951.3M +2.84% | 925.0M +2.05% | 906.4M +2.83% | 881.5M +1.30% | |
Cash Flow | |||||
Cash from Operating Activities | 1.2B -25.30% | 1.6B -26.54% | 2.1B +1,334.68% | -173.0M -110.62% | |
Capital Expenditures | 660.0M -0.45% | 663.0M +19.68% | 554.0M -29.70% | 788.0M +8.09% | |
Cash from Investing Activities | -737.0M +28.62% | -573.0M -9.91% | -636.0M -57.23% | -1.5B -59.50% | |
Dividends Paid | 328.0M +32,700.00% | 1.0M -50.00% | 2.0M -99.51% | 412.0M -14.52% | |
Cash from Financing Activities | 107.0M +121.57% | -496.0M -41.51% | -848.0M -269.60% | 500.0M +121.30% | |
Financials Ratio | |||||
Gross Margin | 45.18% +4.75% | 43.13% +5.22% | 40.99% +1.58% | 40.35% -3.41% | |
Operating Margin | 7.98% +172.00% | 2.94% +563.82% | -0.63% -92.62% | -8.58% -366.08% | |
Return on Assets | 3.41% +247.06% | -2.32% +43.16% | -1.62% -68.90% | -5.21% -145.97% | |
Return on Equity | 8.28% +247.46% | -5.62% +46.08% | -3.85% -66.75% | -11.56% -145.89% | |
Revenue Growth | 11.71% +277.34% | -6.60% -152.29% | 12.63% +222.93% | 3.91% +132.12% | |
Current Ratio | 1.32 +7.51% | 1.23 +2.57% | 1.20 -7.23% | 1.29 -6.90% | |
Cash Ratio | 0.37 +26.26% | 0.29 +30.69% | 0.23 +52.67% | 0.15 -52.22% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow